In silico and in vitro identification of microRNAs that regulate hepatic nuclear factor 4α expression
about
MiRNAs and miRNA Polymorphisms Modify Drug ResponseRelationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosismicroRNA-34a is associated with expression of key hepatic transcription factors and cytochromes P450Age-Related Changes in MicroRNA Expression and Pharmacogenes in Human LiverIdentification of ITPA on chromosome 20 as a susceptibility gene for young-onset tuberculosis.MicroRNA Pharmacoepigenetics: Posttranscriptional Regulation Mechanisms behind Variable Drug Disposition and Strategy to Develop More Effective TherapyFormaldehyde and epigenetic alterations: microRNA changes in the nasal epithelium of nonhuman primates.Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME.Incubation of whole blood at room temperature does not alter the plasma concentrations of microRNA-16 and -223.Regulation of microRNA expression by rifampin in human hepatocytes.BDE47 induces rat CYP3A1 by targeting the transcriptional regulation of miR-23b.Identification of microRNAs dysregulated in cellular senescence driven by endogenous genotoxic stress.Prediction of CYP2D6 phenotype from genotype across world populationsPharmacogenetics of the nuclear hormone receptors: the missing link between environment and drug effects?Hepatocyte nuclear factor 4-alpha involvement in liver and intestinal inflammatory networksMicroRNAs as key regulators of xenobiotic biotransformation and drug response.MicroRNA hsa-miR-370-3p suppresses the expression and induction of CYP2D6 by facilitating mRNA degradation.Transcriptional Regulation of CYP2D6 Expression.MicroRNAs and the metabolic hallmarks of aging.High-Throughput Assays to Assess the Functional Impact of Genetic Variants: A Road Towards Genomic-Driven Medicine.The role of microRNAs in hepatocyte nuclear factor-4alpha expression and transactivation.CYP2D6 and pharmacogenomics: where does future research need to focus? Part 1: technical aspects.Variants in the CYP2B6 3'UTR Alter In Vitro and In Vivo CYP2B6 Activity: Potential Role of MicroRNAs.Regulation of UGT1A expression by miR-298 in human livers from the Han Chinese population and in human cell lines.Pharmacogenetic effects of regulatory nuclear receptors (PXR, CAR, RXRα and HNF4α) on docetaxel disposition in Chinese nasopharyngeal cancer patients.PASSPORT-seq: A Novel High-Throughput Bioassay to Functionally Test Polymorphisms in Micro-RNA Target Sites.CYP450 genotype and pharmacogenetic association studies: a critical appraisal
P2860
Q28079075-0EFCF6AA-521D-44FF-93D5-31438886A706Q34994708-2A4DE830-BBDB-42C7-852E-49C0ED54A1F2Q35063942-13CC1A60-979C-4BAB-AE31-936C671D0A2AQ35883284-E6294430-2929-4A65-AF81-52FBFDEF6476Q35990784-A07FA360-4A63-4460-AC65-D20930547934Q36618667-7A0E76FA-4821-4AE7-AD82-51F25989D018Q36752327-06E0CFE1-ED56-4C5D-91AC-32AFE57C26F1Q37121662-C00097BB-E334-42D4-AD2A-A2C18BE10E52Q37193081-73A7A11B-DD7A-4C6D-A50B-96CCDF4D6667Q37193112-091D93EE-4D1A-476B-97B6-DF4134D1C1F7Q37193395-1F90D984-615C-4D67-926B-F219D22A54D8Q37298895-9244C224-35F2-4D57-B59E-BE6719D3F258Q37625633-CCA50303-9507-4747-8B84-55F1814E586EQ38166454-3D540A85-36A7-43F6-9396-90F7ED50BE50Q38177778-E641E60F-72F4-4E90-8EE6-E01C20ACACE2Q38235604-D0B70B2A-0312-46CD-945D-F50ECAA59981Q38701992-D312EA8F-1BB4-420D-A885-9806FC2C8117Q38971321-734ED305-999B-4FF5-88EF-E9D810F8C312Q39071073-5C5D1286-D07C-4DEA-B8B5-AE2056E07C6DQ39141707-702C0B16-52DC-4252-95F9-776A5A7870CBQ39214366-495C34EA-7EC0-4A2F-8CF7-B5F5E7A5400FQ44023442-67D9790A-AF1E-45C7-88D9-D27732C0CFEDQ47727598-9ED1C29E-5935-4D38-8D83-7DC782E09D6DQ49668137-F33FE2ED-FA48-4054-A259-1DEA911B347AQ50053868-41A68A67-3E1F-4B2B-BD6A-6E27C8F3269CQ55368142-671B637A-6873-4A4D-9227-0A5D8F8BFC45Q57585515-1129F8D7-1585-414B-AC22-45879191AC3C
P2860
In silico and in vitro identification of microRNAs that regulate hepatic nuclear factor 4α expression
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
In silico and in vitro identif ...... c nuclear factor 4α expression
@ast
In silico and in vitro identif ...... c nuclear factor 4α expression
@en
type
label
In silico and in vitro identif ...... c nuclear factor 4α expression
@ast
In silico and in vitro identif ...... c nuclear factor 4α expression
@en
prefLabel
In silico and in vitro identif ...... c nuclear factor 4α expression
@ast
In silico and in vitro identif ...... c nuclear factor 4α expression
@en
P2093
P2860
P356
P1476
In silico and in vitro identif ...... c nuclear factor 4α expression
@en
P2093
Andrea Gaedigk
Anuradha Ramamoorthy
Eric A Benson
L DiAnne Bradford
Todd C Skaar
P2860
P304
P356
10.1124/DMD.111.040329
P577
2012-01-09T00:00:00Z